<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03620721</url>
  </required_header>
  <id_info>
    <org_study_id>STU00207126</org_study_id>
    <nct_id>NCT03620721</nct_id>
  </id_info>
  <brief_title>Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Adults in a FQHC</brief_title>
  <acronym>M-Body</acronym>
  <official_title>Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Low-income, Racial/Ethnic Minority Adults in a Federally Qualified Health Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this project is to examine the clinical effectiveness of a mindfulness
      intervention on reducing depressive symptoms among socio-economically disadvantaged,
      racial/ethnic minority adults and explore factors related to implementation in a Federally
      Qualified Health Center (FQHC). This research will be used to develop a generalizable model
      for delivery of streamlined mental health interventions in community based settings that will
      be broadly disseminated and scalable to other populations. Black and Hispanic adults are more
      likely than those who are White to receive depression treatment in primary care, where
      antidepressants are the most commonly offered treatment. However, Black and Hispanic adults
      are less likely than Whites to find antidepressants acceptable. A mindfulness depression
      intervention provided within primary care may be more accessible and acceptable for
      low-income, racial/ethnic minority individuals, a severely underserved population. The
      investigators will conduct a randomized controlled trial to test the clinical effectiveness
      of a mindfulness intervention (M-Body) on reducing depressive symptoms, compared to usual
      care, among low-income racial/ethnic minority adults in a FQHC. The M-Body intervention is
      based on Mindfulness Based Stress Reduction and has been tailored for the FQHC setting and
      patient population. Adults (N=330) with depressive symptoms will be recruited from a FQHC in
      the Chicago, IL area that serves majority racial/ethnic minority individuals (90%) living at
      or below the poverty line (74%). Half of the patients will be randomized to the M-Body
      intervention arm where they will receive 8-weeks of mindfulness training led by FQHC staff
      and the other half will be randomized to usual care. Information on factors relevant to
      implementation of the intervention in the FQHC will be obtained by convening a series of
      workgroups and individual interviews with FQHC staff, executive leadership and community
      stakeholders. Specific Aims: 1) Determine the effectiveness of M-Body on reducing depressive
      symptoms compared to enhanced usual care for racial/ethnic minority adults in a FQHC; 2)
      Explore potential mediators (stress related biomarkers, mindfulness) and moderators (age,
      personal, social, environmental stressors) of the intervention's effect; 3) Conduct a broad
      assessment of organizational and individual agency factors related to preparation and
      implementation of the M-Body intervention in a FQHC using a mixed methods approach.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depressive Symptoms</measure>
    <time_frame>6 months</time_frame>
    <description>Inventory of Depressive Symptoms (IDS-C), 30 items rated on a 0-3 point scale, total scores range from 0-84</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>6 months</time_frame>
    <description>Generalized Anxiety Disorder (GAD-7), 7 items, rated on a 0-3 point scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anger</measure>
    <time_frame>6 months</time_frame>
    <description>Anger Self-Report Questionnaire (ASRQ), 30 items rated on a 1-6 point scale</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Self-reported Stress</measure>
    <time_frame>6 months</time_frame>
    <description>Perceived Stress Scale (PSS), 10 items rated on a 0-4 point scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Mindfulness</measure>
    <time_frame>6 months</time_frame>
    <description>Five Facet Mindfulness Questionnaire (FFMQ), 14 items rated on a 1-5 point scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Cognitive Reactivity</measure>
    <time_frame>6 months</time_frame>
    <description>Cognitive Emotion Regulation Questionnaire (CERQ), 36 items rated on a 1-5 point scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Self-Compassion</measure>
    <time_frame>6-months</time_frame>
    <description>Self Compassion Scale (SCS), 26 items rated on a 1-5 point scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Affective Dysregulation</measure>
    <time_frame>6 months</time_frame>
    <description>Difficulties in Emotion Regulation Scale (DERS), 36 items rated on a 1-5 point scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Negative Thinking</measure>
    <time_frame>6 months</time_frame>
    <description>Reflection and Rumination Questionnaire (RRQ), 24 items rated on a 1-5 point scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Social Functioning</measure>
    <time_frame>Baseline</time_frame>
    <description>Social Problems Questionnaire (SPQ), 33 items rated on a 0-3 point scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Traumatic Life Events</measure>
    <time_frame>6 months</time_frame>
    <description>PTSD Checklist for DSM-5 (PCL-5) with Life Events Checklist-5 (LEC-5), 20 items rated on a 0-4 point scale with an additional 17 items checklist</description>
  </other_outcome>
  <other_outcome>
    <measure>Spirituality</measure>
    <time_frame>Baseline</time_frame>
    <description>Spirituality Scale (SS), 8 items rated on a 1-6 point scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Baseline, 8, 16, and 24 weeks</time_frame>
    <description>Ranges of blood pressure measurements (mmHg)</description>
  </other_outcome>
  <other_outcome>
    <measure>Inflammatory Biomarkers</measure>
    <time_frame>Baseline, 8, 16, and 24 weeks</time_frame>
    <description>Dried Blood Spot (DBS) samples will be assessed for inflammatory biomarkers (CRP, IL6, and IL8)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">330</enrollment>
  <condition>Depressive Symptoms</condition>
  <condition>Stress, Psychological</condition>
  <condition>Stress, Physiological</condition>
  <arm_group>
    <arm_group_label>M-Body</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mindfulness group intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>treatment as usual</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>mindfulness</intervention_name>
    <description>8-week mindfulness based group intervention</description>
    <arm_group_label>M-Body</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 years old

          -  mild to severe depressive symptoms (Patient Health Questionnaire-9, PHQ-9, total score
             ≥ 5)

          -  English speaking

        Exclusion Criteria:

          -  PHQ-9 total score &lt;5

          -  past 30-day suicidal ideation

          -  current, regular practice of meditation or yoga (≥ 4 per week)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lynette Lartey, MPH</last_name>
    <phone>3126956250</phone>
    <email>lynette.lartey@northwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Victoria Wee, BA</last_name>
    <phone>3129262188</phone>
    <email>victoria.wee@northwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwestern University Asher Center for the Study and Treatment of Depressive Disorders</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynette Lartey, MPH</last_name>
      <phone>312-695-6250</phone>
      <email>lynette.lartey@northwestern.edu</email>
    </contact>
    <contact_backup>
      <last_name>Victoria Wee, BA</last_name>
      <phone>312-926-2188</phone>
      <email>victoria.wee@northwestern.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Inger E. Burnett-Zeigler, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 23, 2018</study_first_submitted>
  <study_first_submitted_qc>August 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2018</study_first_posted>
  <last_update_submitted>December 12, 2019</last_update_submitted>
  <last_update_submitted_qc>December 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Inger Burnett-Zeigler</investigator_full_name>
    <investigator_title>Assosciate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Stress, Psychological</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

